Abstract :Clostridium difficile Infections (CDI) is increasing in recipients of Solid Organ Transplant (SOT).
These patients are at a particularly elevated risk due to comorbid conditions, lengthy hospital
stays, recurrent use of antibiotics and immunosuppressive status. CDI are more challenging to
diagnose in this group of patients and contribute to a significantly increased mortality, morbidity
and recurrence. Preventive measures and early diagnosis remain key in the management of CDI in
transplant recipients in order to abort the associated complications.